These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29664691)

  • 21. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
    Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
    Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
    Biroscak BJ; Fiore AE; Fasano N; Fineis P; Collins MP; Stoltman G
    Pediatrics; 2003 Jun; 111(6 Pt 1):e645-9. PubMed ID: 12777580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
    Posuwan N; Wanlapakorn N; Vongpunsawad S; Sintusek P; Leuridan E; Van Damme P; Poovorawan Y
    Vaccine; 2020 Feb; 38(7):1643-1651. PubMed ID: 31948817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.
    Wang C; Wang C; Jia ZF; Wu X; Wen SM; Kong F; Hu KQ; Li J; Jiang J; Niu JQ
    Medicine (Baltimore); 2016 Aug; 95(34):e4390. PubMed ID: 27559947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Wei KP; Zhu FC; Liu JX; Yan L; Lu Y; Zhai XJ; Chang ZJ; Zeng Y; Li J; Zhuang H
    Vaccine; 2018 Jan; 36(2):256-263. PubMed ID: 29195717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen-positive/hepatitis B e antigen-negative carriers.
    Zamir C; Dagan R; Zamir D; Rishpon S; Fraser D; Rimon N; Ben Porath E
    Pediatr Infect Dis J; 1999 Mar; 18(3):262-6. PubMed ID: 10093949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
    Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.
    Vranckx R; Alisjahbana A; Meheus A
    J Viral Hepat; 1999 Mar; 6(2):135-9. PubMed ID: 10607224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule.
    Han K; Shao X; Zheng H; Wu C; Zhu J; Zheng X; Zhang Y
    Hum Vaccin Immunother; 2012 Dec; 8(12):1845-9. PubMed ID: 22906933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen.
    Jan CF; Liu TH; Ho CH; Chien YC; Chang CJ; Guo FR; Huang KC
    Fam Pract; 2020 Feb; 37(1):30-35. PubMed ID: 31375819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.
    Lee PI; Lee CY; Huang LM; Chang MH
    J Pediatr; 1995 May; 126(5 Pt 1):716-21. PubMed ID: 7751994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.